The Impact of Pulmonary Rehabilitation in Interstitial Lung Disease

Completed

• Conditions: Interstitial Lung Disease
• Interventions: Other: Pulmonary rehabilitation

• Registration Number: NCT01055730
• Lead Sponsor: University of California, San Francisco

Brief Summary

The purpose of this study is to determine if pulmonary rehabilitation has any effect on breathlessness, quality of life, physical function and depression in persons with interstitial lung disease.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2010-01-25
• Study First Submitted QC: 2010-01-25
• Study First Posted: 2010-01-26
• Study Start: 2010-02
• Primary Completion: 2013-01
• Study Completion: 2013-01
• Status Verified: 2013-11
• Last Update Submitted: 2013-11-19
• Last Update Posted: 2013-11-21

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 54

Inclusion Criteria

• Adults (> 18 years old) with a diagnosis of ILD who are referred to a participating PR program

Read More

Exclusion Criteria

• Inability to provide informed consent
• Inability to read and write English
• Any other medical condition that significantly limits the subject's ability to perform the functional measures
• Emphysema / Chronic bronchitis (FEV1 / FVC ratio < 60%)
• Previous pulmonary rehabilitation

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Pulmonary rehabilitation	Pulmonary rehabilitation	-

Primary Outcome Measures

Name	Time	Method
Quality of life	Immediately following completion of pulmonary rehabilitation and 6 months following the start of pulmonary rehabilitation
6-minute walk distance	Immediately following completion of pulmonary rehabilitation and 6 months following the start of pulmonary rehabilitation

Secondary Outcome Measures

Name	Time	Method
Dyspnea	Immediately following completion of pulmonary rehabilitation and 6 months following the start of pulmonary rehabilitation
Depression	Immediately following completion of pulmonary rehabilitation and 6 months following the start of pulmonary rehabilitation

Trial Locations

Locations (6)

Inova Fairfax Hospital; 🇺🇸 Falls Church, Virginia, United States

John Muir Health; 🇺🇸 Concord, California, United States

Yale University School of Medicine; 🇺🇸 New Haven, Connecticut, United States

Duke University Medical Center; 🇺🇸 Durham, North Carolina, United States

Seton Pulmonary & Cardiac Rehabilitation; 🇺🇸 Daly City, California, United States

University of British Columbia; 🇨🇦 Vancouver, British Columbia, Canada